YMTX insider filings

YUMANITY THERAPEUTICS, INC. — 49 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-12-06. Screen YMTX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for YMTX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — YUMANITY THERAPEUTICS, INC.

FiledFormInsiderReported transactionsSource
2022-12-064Peters Richard — President and CEO, DirectorSale (S): 10,890 @ $1.69EDGAR
2022-12-064Wyzga Michael D — See RemarksSale (S): 3,116 @ $1.69EDGAR
2022-12-064Epstein Marie — Principal Accounting OfficerSale (S): 1,976 @ $1.69EDGAR
2022-12-064Smith Devin Whittemore — SVP and General CounselSale (S): 3,116 @ $1.69EDGAR
2022-07-064Peters Richard — President and CEO, DirectorSale (S): 4,584 @ $1.85EDGAR
2022-06-064Epstein Marie — Principal Accounting OfficerSale (S): 1,806 @ $1.19EDGAR
2022-06-064Smith Devin Whittemore — SVP and General CounselSale (S): 2,923 @ $1.19EDGAR
2022-06-064Wyzga Michael D — See RemarksSale (S): 2,887 @ $1.19EDGAR
2022-06-064Peters Richard — President and CEO, DirectorSale (S): 10,206 @ $1.19EDGAR
2022-03-304Peters Richard — President and CEO, DirectorSale (S): 10,715 @ $1.85EDGAR
2022-02-074Mohsen Paulash — Chief Business OfficerSale (S): 1,958 @ $1.83EDGAR
2021-12-034Verma Ajay — EVP, Head of R&DGrant/award (A): 30,000 @ $0EDGAR
2021-12-034Epstein Marie — Principal Accounting OfficerGrant/award (A): 12,665 @ $0EDGAR
2021-12-034Wyzga Michael D — See RemarksGrant/award (A): 20,000 @ $0EDGAR
2021-12-034Mohsen Paulash — Chief Business OfficerGrant/award (A): 20,000 @ $0EDGAR
2021-12-034Smith Devin Whittemore — SVP and General CounselGrant/award (A): 20,000 @ $0EDGAR
2021-12-034Peters Richard — President and CEO, DirectorGrant/award (A): 70,000 @ $0EDGAR
2021-11-154Verma Ajay — EVP, Head of R&DGrant/award (A): 5,000 (derivative) @ $0EDGAR
2021-08-174Wyzga Michael D — See RemarksGrant/award (A): 65,000 (derivative) @ $0EDGAR
2021-07-074Peters Richard — President and CEO, DirectorTax withholding (F): 4,441 @ $11.11 · Tax withholding (F): 79 @ $10.79EDGAR
2021-06-164Smith Devin Whittemore — SVP and General CounselGrant/award (A): 58,400 (derivative) @ $0EDGAR
2021-06-044Kelly Jeffery W. — DirectorGrant/award (A): 14,800 (derivative) @ $0EDGAR
2021-06-044Heyman Richard A. — DirectorGrant/award (A): 14,800 (derivative) @ $0EDGAR
2021-06-044Zydowsky Lynne — DirectorGrant/award (A): 14,800 (derivative) @ $0EDGAR
2021-06-044Allen Patricia L — DirectorGrant/award (A): 14,800 (derivative) @ $0EDGAR
2021-06-044Drapkin Kimberlee C — DirectorGrant/award (A): 14,800 (derivative) @ $0EDGAR
2021-06-044Arkowitz David — DirectorGrant/award (A): 14,800 (derivative) @ $0EDGAR
2021-06-044PICKETT CECIL B — DirectorGrant/award (A): 14,800 (derivative) @ $0EDGAR
2021-04-154Verma Ajay — EVP, Head of R&DGrant/award (A): 84,000 (derivative) @ $0EDGAR
2021-04-024COLES N ANTHONY — Executive Chair, DirectorGrant/award (A): 78,650 (derivative) @ $0EDGAR
2021-02-034Mohsen Paulash — Chief Business OfficerGrant/award (A): 4,665 @ $0 · Grant/award (A): 37,596 (derivative) @ $0EDGAR
2021-02-034Peters Richard — President & CEO, DirectorGrant/award (A): 60,943 @ $0 · Grant/award (A): 120,000 (derivative) @ $0 · Grant/award (A): 60,944 (derivative) @ $0EDGAR
2021-02-034Epstein Marie — Principal Accounting OfficerGrant/award (A): 13,329 (derivative) @ $0EDGAR
2021-02-034Robertson Brigitte — Chief Medical OfficerGrant/award (A): 25,064 (derivative) @ $0EDGAR
2021-02-034Kelly Jeffery W. — DirectorGrant/award (A): 1,959 @ $0EDGAR
2021-02-034Heyman Richard A. — DirectorGrant/award (A): 1,959 @ $0EDGAR
2021-02-034PICKETT CECIL B — DirectorGrant/award (A): 1,959 @ $0EDGAR
2021-02-034COLES N ANTHONY — Executive Chair, DirectorGrant/award (A): 1,118 @ $0EDGAR
2020-12-284Epstein Marie — Principal Accounting OfficerGrant/award (A): 38,373 (derivative) · Grant/award (A): 4,216 (derivative)EDGAR
2020-12-284Peters Richard — President and CEO, DirectorGrant/award (A): 235,237 (derivative)EDGAR
2020-12-284Robertson Brigitte — Chief Medical OfficerGrant/award (A): 59,035 (derivative)EDGAR
2020-12-284Mohsen Paulash — Chief Business OfficerGrant/award (A): 36,428 · Grant/award (A): 42,168 (derivative) · Grant/award (A): 10,542 (derivative)EDGAR
2020-12-284Kelly Jeffery W. — DirectorGrant/award (A): 6,158 · Grant/award (A): 5,271 (derivative)EDGAR
2020-12-284Zydowsky Lynne — DirectorGrant/award (A): 12,495 (derivative) · Grant/award (A): 5,271 (derivative)EDGAR
2020-12-284Heyman Richard A. — DirectorGrant/award (A): 6,158 · Grant/award (A): 5,271 (derivative)EDGAR
2020-12-284Allen Patricia L — DirectorGrant/award (A): 12,495 (derivative) · Grant/award (A): 5,271 (derivative)EDGAR
2020-12-284Arkowitz David — DirectorGrant/award (A): 4,347 @ $23EDGAR
2020-12-284PICKETT CECIL B — DirectorGrant/award (A): 6,158 · Grant/award (A): 5,271 (derivative)EDGAR
2020-12-284COLES N ANTHONY — Executive Chair, DirectorGrant/award (A): 689,890 · Grant/award (A): 52,669 · Grant/award (A): 72,496 (derivative) · Grant/award (A): 12,082 (derivative) · Grant/award (A): 6,038 (derivative)EDGAR

Recent 8-K events — YUMANITY THERAPEUTICS, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2025-07-018-K2.01 — Completion of Acquisition or Disposition of Assets
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-06-248-K5.07 — Submission of Matters to a Vote of Security Holders
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-05-078-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2025-03-288-K4.01 — Changes in Registrant's Certifying Accountant
9.01 — Financial Statements and Exhibits
EDGAR
2025-03-078-K3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2025-02-108-K8.01 — Other EventsEDGAR
2024-12-128-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-11-258-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-11-088-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-10-088-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=YMTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs